| Dr Garabed Gary Demerjian, DDS | |
|
175 N Pennsylvania Ave Ste 4, Glendora, CA 91741-3316 | |
| (626) 852-1865 | |
| (626) 963-3316 |
| Full Name | Dr Garabed Gary Demerjian |
|---|---|
| Gender | Male |
| Speciality | Dentist |
| Location | 175 N Pennsylvania Ave Ste 4, Glendora, California |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235203332 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 122300000X | Dentist | 38514 (California) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Dr Garabed Gary Demerjian, DDS 175 N Pennsylvania Ave Ste 4, Glendora, CA 91741-3316 Ph: (626) 852-1865 | Dr Garabed Gary Demerjian, DDS 175 N Pennsylvania Ave Ste 4, Glendora, CA 91741-3316 Ph: (626) 852-1865 |
News Archive
Reuters reports a softening in demand for hospital chains and device makers, among others. Meanwhile, law enforcement officials warn of insurance scams that play on confusion over the health care overhaul.
Using an innovative method to control the movement of Escherichia coli in a chemical environment, Emory University scientists have opened the door to powerful new opportunities in drug delivery, environmental cleanup and synthetic biology.
MannKind Corporation today announced that it has submitted, and the U.S. Food and Drug Administration has accepted, MannKind's resubmission of its New Drug Application for AFREZZA™ (insulin human [rDNA origin]) and classified it as a Class 2 resubmission. With the Class 2 designation, the FDA set a corresponding Prescription Drug User Fee Act action date of December 29, 2010.
Young adults and adolescents who are prescribed opioids for the first time may be at a slightly greater risk of developing a substance-related problem later in life, according to a new study co-authored by Indiana University researchers. However, the risk may not be as high as previously thought.
Data from the 48-week ART trial, presented today at the Digestive Disease Week meeting, showed that remission and response rates were 37.2% and 53.2% respectively at week 12, in patients with moderate-to-severe, steroid-dependent active ulcerative colitis (UC) with insufficient response or intolerance to immunosuppressants and / or biologics when treated with between five and eight sessions with Adacolumn.
› Verified 3 days ago
Frankie C Ngo, DMD Dentist Medicare: Not Enrolled in Medicare Practice Location: 605 W Route 66, Glendora, CA 91740 Phone: 626-771-1320 | |
Joseph A Geleris, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 175 N Pennsylvania, # 3, Glendora, CA 91741 Phone: 626-963-7519 Fax: 626-335-8212 | |
Dr. Patricia Kathleen Donnelly, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 410 S Glendora Ave #250, Glendora, CA 91741 Phone: 626-963-4464 Fax: 626-963-4166 | |
John Bunkers, Dentist Medicare: Not Enrolled in Medicare Practice Location: 2220 E Route 66, Suite 107, Glendora, CA 91740 Phone: 626-857-4702 Fax: 626-857-4703 | |
Dr. Ibrahim Irawan, D.D.S. Dentist Medicare: Medicare Enrolled Practice Location: 505 E Arrow Hwy, Glendora, CA 91740 Phone: 626-335-2899 Fax: 626-335-3892 | |
Jamison Jon Pawley, DMD MS Dentist Medicare: Not Enrolled in Medicare Practice Location: 175 N Pennsylvania Ave #6, Glendora, CA 91741 Phone: 626-963-4173 Fax: 626-963-6573 | |
Dr. Emad M Ammar, DDS Dentist Medicare: Not Enrolled in Medicare Practice Location: 175 N Pennsylvania Ave, Ste #5, Glendora, CA 91741 Phone: 626-335-6888 Fax: 626-335-0277 |